Company profile for Avanthi Pharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Avanthi, Inc. develops high quality prescription and OTC pharmaceuticals in the United States. The company is committed to developing various dosage forms that include immediate and modified release tablets, capsules, liquids and semisolid dosage forms. Our products are available throughout the United States from pharmaceutical wholesalers, distributors, chain drug stores and managed care organizations. The business enviro...
Avanthi, Inc. develops high quality prescription and OTC pharmaceuticals in the United States. The company is committed to developing various dosage forms that include immediate and modified release tablets, capsules, liquids and semisolid dosage forms. Our products are available throughout the United States from pharmaceutical wholesalers, distributors, chain drug stores and managed care organizations. The business environment in which Avanthi, Inc. participates is dynamic. External factors such as population demographics and healthcare funding/expenditures continue to present new challenges.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
110 Terry Drive, Suite 100. Newtown, PA 18940
Telephone
Telephone
1-(215)-579-0260
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

http://www.prnewswire.com/news-releases/avant-diagnostics-newly-appointed-president--ceo-philippe-goix-delivered-an-address-to-shareholders-648310843.html

PR NEWSWIRE
27 Sep 2017

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207176

FDA
09 Aug 2017

https://www.pharmacompass.com/pdf/news/avanthi-inc-generic-phentermine-hydrochloride-approved-in-us-1473939022.pdf

FDA
13 Sep 2016

https://www.pharmacompass.com/pdf/news/avanthis-generic-dextroamphetamine-sulfate-approved-in-usdeficit-disorder-1448540706.pdf

FDA
24 Nov 2015

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty